# Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion

> **NCT00970957** · PHASE3 · COMPLETED · sponsor: **Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA** · enrollment: 107 (actual)

## Conditions studied

- Macular Edema
- Retinal Vein Occlusion

## Interventions

- **DRUG:** Avastin Intravitreal Injection
- **DRUG:** Sham Avastin Intravitreal Injection

## Key facts

- **NCT ID:** NCT00970957
- **Lead sponsor:** Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2014-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00970957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00970957, "Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00970957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*